Waldenstrom's Macroglobulinemia Program Dana-Farber Cancer Institute
  Publications
  Media
 
 
  Email this page to a friend >

 

   
  Bortezomib as a Treatment Option in Patients With Waldenstrom Macroglobulinemia
4/6/2010
By M Dimopoulos, C Chen, E Kastritis, M Gavriatopoulou, SP Treon
Publisher: Clinical Lymphoma, Myeloma & Leukemia

Please see attachment
View Attachment


<< Back